Food and Drug Administration–Approved Fecal Microbiota–Based Therapies for Recurrent Clostridioides difficile Infection

Gastroenterology Clinics of North America · Published 2026-06-17 · DOI 10.1016/j.gtc.2026.05.010

Authors (3)

Parul Berry, Jessica R. Allegretti, Sahil Khanna

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Berry, P., Allegretti, J., Khanna, S. (2026). Food and Drug Administration–Approved Fecal Microbiota–Based Therapies for Recurrent Clostridioides difficile Infection. Gastroenterology Clinics of North America. https://doi.org/10.1016/j.gtc.2026.05.010

Related articles